Common Stock, Shares, Outstanding of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Dianthus Therapeutics, Inc. /DE/ Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 43,223,090, a 39% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 43,223,090 +12,107,749 +39% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 42,854,563 +13,488,211 +46% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 32,176,482 +2,824,342 +9.6% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 32,125,933 +2,777,307 +9.5% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 31,115,341 +16,297,645 +110% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 29,366,352 +14,548,590 +98% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 29,352,140 -31,300,057 -52% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 29,348,626 -31,300,195 -52% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 14,817,696 +13,942,417 +1593% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 14,817,762 -45,737,758 -76% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 60,652,197 +1,853,040 +3.2% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 60,648,821 +1,849,664 +3.1% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 875,279 0 0% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 60,555,520 +1,778,249 +3% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 58,799,157 +290,422 +0.5% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 58,799,157 +10,195,952 +21% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 875,279 -47,657,856 -98% 31 Dec 2021 8-K 21 Dec 2023
Q3 2021 58,777,271 +10,483,802 +22% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 58,508,735 +10,267,523 +21% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 48,603,205 +9,148,570 +23% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 48,533,135 +9,272,603 +24% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 48,293,469 +9,350,750 +24% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 48,241,212 +9,530,354 +25% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 39,454,635 +5,872,660 +17% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 39,260,532 +5,955,499 +18% 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q3 2019 38,942,719 +5,840,552 +18% 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 38,710,858 +5,821,802 +18% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 33,581,975 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 33,305,033 +30,953,786 +1316% 31 Dec 2018 10-K 03 Mar 2020 2019 FY
Q3 2018 33,102,167 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 32,889,056 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q4 2017 2,351,247 31 Dec 2017 10-K 19 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.